In a monotherapy setting, participants receiving oral semaglutide at 7 mg and 14 mg experienced mean HbA1c reductions of 1.3% and 1.5%, respectively, while those on empagliflozin (25 mg), sitagliptin (100 mg), and liraglutide (1.8 mg) showed lesser reductions, highlighting the efficacy of oral semaglutide
The bigger picture: choosing your GLP-1 path Pomegranate Health is one option in a rapidly expanding market
If you are considering semaglutide, consult with your healthcare provider to determine if it is the right choice for you
Ozempic pens have built-in dose counters and windows to help you know when your pen is empty
In one real-world study, patients on tirzepatide lost 15.3% of their body weight at 12 months, compared to 8.3% for those on semaglutide